More on TNXP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.44 |
|
|||
| Open | $12.63 | ||||
| 52 Wk High | $7.95 | ||||
| 52 Wk Low | $0.40 | ||||
| Day High | $12.99 | ||||
| Day Low | $12.13 | ||||
| P/E | N/A | ||||
| EPS | $-5.33 | ||||
| Volume | 326,683 | ||||
- Form S-8 Tonix Pharmaceuticals
- Tonix enrolls first patient in Phase 2 MDD study of TNX-102 SL
- Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
- Form 8-K Tonix Pharmaceuticals For: Jun 29
- Raymond James Starts Tonix Pharma (TNXP) at Strong Buy
- Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
- Form 4 Tonix Pharmaceuticals For: Jun 12 Filed by: Taylor Carolyn E.
- Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026
- Form 4 Tonix Pharmaceuticals For: Jun 08 Filed by: Stillwell Richard Newcomb
- Form 4 Tonix Pharmaceuticals For: Jun 09 Filed by: LEDERMAN SETH
Entities mentioned with TNXP
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- S3 | View Related Stories »
- Show More...
